Taken together, effects of PXL770 seen in patient cells were largely confirmed in ALD mouse glial cells – including normalization of VLCFA levels, stimulation of mitochondrial oxidative phosphorylation parameters, as well as upregulation of Abcd2 and Abcd3 mRNAs. This evidence concerns the gene ABCD2 and adrenoleukodystrophy.